These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27161970)

  • 1. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.
    Accordino MK; Wright JD; Vasan S; Neugut AI; Hillyer GC; Hu JC; Hershman DL
    J Clin Oncol; 2016 Aug; 34(24):2820-6. PubMed ID: 27161970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-cost imaging in elderly patients with stage IV cancer.
    Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
    J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor marker usage and medical care costs among older early-stage breast cancer survivors.
    Ramsey SD; Henry NL; Gralow JR; Mirick DK; Barlow W; Etzioni R; Mummy D; Thariani R; Veenstra DL
    J Clin Oncol; 2015 Jan; 33(2):149-55. PubMed ID: 25332254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life.
    Golan R; Bernstein AN; Gu X; Dinerman BF; Sedrakyan A; Hu JC
    Cancer; 2018 May; 124(10):2212-2219. PubMed ID: 29579318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

  • 6. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
    Vyas AM; Aroke H; Kogut S
    J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer.
    Di Meglio A; Lin NU; Freedman RA; Barry WT; Winer EP; Vaz-Luis I
    J Natl Compr Canc Netw; 2017 Mar; 15(3):316-324. PubMed ID: 28275032
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
    Hao Y; Li N; Fang AP; Koo V; Peeples M; Kageleiry A; Wu EQ; Guérin A
    Adv Ther; 2016 Jun; 33(6):983-97. PubMed ID: 27216253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced imaging and hospice use in end-of-life cancer care.
    Dinan MA; Curtis LH; Setoguchi S; Cheung WY
    Support Care Cancer; 2018 Oct; 26(10):3619-3625. PubMed ID: 29728843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study.
    Baird CE; Wulff-Burchfield E; Egan PC; Hugar LA; Vyas A; Trikalinos NA; Liu MA; Bélanger E; Olszewski AJ; Bantis LE; Panagiotou OA
    J Geriatr Oncol; 2024 Jun; 15(5):101774. PubMed ID: 38676975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021.
    Jaber Chehayeb R; Hood A; Wang X; Miksad R; Schellhorn Mougalian S; Lustberg MB; Wang SY; Greenup RA; Pusztai L; Kunst N
    JAMA Netw Open; 2022 Nov; 5(11):e2244204. PubMed ID: 36445704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study.
    Bonotto M; Basile D; Gerratana L; Bartoletti M; Lisanti C; Pelizzari G; Vitale MG; Fanotto V; Poletto E; Minisini AM; Russo S; Andreetta C; Mansutti M; Fasola G; Puglisi F
    Future Oncol; 2020 Sep; 16(27):2059-2073. PubMed ID: 32598185
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population.
    Kruse GB; Amonkar MM; Smith G; Skonieczny DC; Stavrakas S
    J Manag Care Pharm; 2008; 14(9):844-57. PubMed ID: 19006441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
    Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population.
    Crivello ML; Ruth K; Sigurdson ER; Egleston BL; Evers K; Wong YN; Boraas M; Bleicher RJ
    Ann Surg Oncol; 2013 Jan; 20(1):102-10. PubMed ID: 22878617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.
    Ramsey SD; Fedorenko C; Chauhan R; McGee R; Lyman GH; Kreizenbeck K; Bansal A
    J Oncol Pract; 2015 Jul; 11(4):338-43. PubMed ID: 26060225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
    Wilson LE; Pollack CE; Greiner MA; Dinan MA
    Breast Cancer Res Treat; 2018 Jul; 170(2):361-371. PubMed ID: 29536319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between survival time with metastatic breast cancer and aggressive end-of-life care.
    Accordino MK; Wright JD; Vasan S; Neugut AI; Gross T; Hillyer GC; Hershman DL
    Breast Cancer Res Treat; 2017 Nov; 166(2):549-558. PubMed ID: 28752188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.